Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

3.495 -0.075 (-2.10%)
Streaming Delayed Price Updated: 9:51 AM EST, Feb 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 1,412
Open 3.480
Bid (Size) 3.470 (1,000)
Ask (Size) 3.550 (100)
Prev. Close 3.570
Today's Range 3.480 - 3.520
52wk Range 2.521 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
+10.6%
+10.6%
1 Month
-0.7%
-0.7%
3 Month
-6.7%
-6.7%
6 Month
-34.3%
-34.3%
1 Year
-24.4%
-24.4%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 3.495
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 02/10/26 09:51 AM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 7.28B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.